Benjamin Hickey, President, RayzeBio Org: Bristol Myers Squibb BMY Sell · Filed 25/05/13

Trade details

Type: Insider sale
Amount: $3,701.79
Shares · price: 97.39 sh · $38.01 a share
Held after: 0 sh
Stock: Bristol Myers Squibb BMY
Person: Benjamin HickeyPresident, RayzeBio Org
Trade date: 25/05/09
Filed: 25/05/13
Days to filing: 4 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Bristol Myers Squibb trades, last 26 weeks

What else happened in Bristol Myers Squibb around then

Filed or reported within 30 days of the trade day · 25/04/09~25/06/08

Benjamin Hickey's recent trades

Benjamin HickeyEVP, Chief Commercial Officer
SellMirati Therapeutics
Sell
Mirati Therapeutics
MRTX
$57K
966 sh
$57K
Filed 24/01/18
Traded 24/01/16
Benjamin HickeyEVP, Chief Commercial Officer
SellMirati Therapeutics
Sell
Mirati Therapeutics
MRTX
$37.2K
631 sh
$37.2K
Filed 24/01/18
Traded 24/01/16
Benjamin HickeyEVP, Chief Commercial Officer
SellMirati Therapeutics
Sell
Mirati Therapeutics
MRTX
$123.1K
2,090 sh
$123.1K
Filed 24/01/09
Traded 24/01/08
Benjamin HickeyEVP, Chief Commercial Officer
SellMirati Therapeutics
Sell
Mirati Therapeutics
MRTX
$125.8K
2,220 sh
$125.8K
Filed 23/12/14
Traded 23/12/13
Benjamin HickeyEVP, Chief Commercial Officer
SellMirati Therapeutics
Sell
Mirati Therapeutics
MRTX
$40.1K
947 sh
$40.1K
Filed 23/01/19
Traded 23/01/17

Benjamin Hickey, President — sold $3,702 of Bristol Myers Squibb BMY · 100.0% of holdings | Whalegun